Mary Michele Sunshine, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 505 Pope Ave, Fort Leavenworth, KS 66027 Phone: 913-684-6230 |
News Archive
New research has found that it may be possible to predict if people with mild memory and thinking impairments will go onto develop Alzheimer's disease using eye-tracking technology.
Doctors have urged an immediate review of the anti-smoking laws in light of such alarming facts. They want a ban on smoking in public places and cars.
Findings from a study carried out in mice suggest that an intermittent dosing strategy may be the answer to combating lethal tumor resistance to the BRAF inhibitor vemurafenib, in patients with late-stage BRAF-mutated melanoma.
Bristol-Myers Squibb Company and Pfizer today announced that the companies have agreed to stop the Phase 3 AVERROES clinical trial of apixaban in patients with atrial fibrillation. The study will be stopped early because a predefined interim analysis by the independent Data Monitoring Committee (DMC) revealed clear evidence of a clinically important reduction in stroke and systemic embolism in patients with atrial fibrillation considered intolerant of or unsuitable for vitamin K antagonist therapy who received apixaban as compared to aspirin.
› Verified 6 days ago